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Signaling mechanisms underlying the induction of the pre-pancreatic tissue within the endoderm remain poorly understood. Through an
expression cloning strategy, we have identified a previously uncharacterized pancreatic factor that we named Shirin. Interestingly, the non-coding
RNA regulatory sequence (3′UTR) of Shirin is sufficient to induce insulin expression in Xenopus embryos. Biochemical studies demonstrate that
this RNA sequence is able to bind directly to a trans-acting factor, Vg1RBP, which was previously shown to be involved in the localization of
endodermal determinant factors. Loss-of-function analysis indicates that Vg1RBP is required for establishment of pancreatic fate within the
endoderm, suggesting a synergism between Vg1RBP and Shirin in the embryo. This study argues for a central role of post-transcriptional
mechanisms in establishing pancreatic fate, where a 3′UTR may recruit factors necessary for pancreatic development, and highlights an unknown
embryological activity of Vg1RBP.
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During embryonic development, the endodermal germ layer
is fated to form organs of the gastrointestinal and respiratory
tracts, including the liver, pancreas, lung (Grapin-Botton and
Melton, 2000). A complete understanding of the inductive
mechanisms promoting the formation of these tissues within the
endoderm will provide insight into development, disease and
possible strategies for cell therapy. In this study, we focused on
the molecular mechanisms underlying the establishment of the
pre-pancreatic region within the endoderm.
The pancreas is composed of two distinct tissues endowed
with endocrine and exocrine functions (Slack, 1995). Mature
endocrine cells secrete hormones that control glucose homeo-
stasis. Among these, the β-cells are key metabolic regulators,
and their loss or dysfunction leads to diabetes mellitus (Edlund,
2002). In vertebrates, the pancreas originates from distinct
embryonic outgrowths of the dorsal and ventral regions of the⁎ Corresponding author. Fax: +1 212 327 8685.
E-mail address: brvnlou@rockefeller.edu (A.H. Brivanlou).
0012-1606/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2006.01.022duodenal portion of the endoderm, which subsequently fuse to
form a single organ (Slack, 1995). The development of the
pancreas relies on reciprocal interactions of the pre-pancreatic
endoderm with the surrounding tissues (Horb and Slack, 2001;
Kim and Hebrok, 2001; Lammert et al., 2001). During
pancreatic induction, the dorsal and ventral buds are exposed
to different mesodermal stimuli (Bort et al., 2004; Kumar et al.,
2003). All of the signaling sources involved in dorsal pancreatic
induction, including the notochord, dorsal aorta, and mesen-
chyme, have been shown to act as permissive rather than
instructive signals on endoderm that has already received a
“pancreatic pre-pattern” (Edlund, 2002). Recent tissue recom-
bination experiments in chick have shown that lateral plate
mesoderm, which contacts ventral pancreatic endoderm, may
release instructive signals and induce ectopic ventral pancreatic
identity in endoderm, normally fated to form more rostral
organs (Kumar et al., 2003). However, the molecular identities
of the signals released by all these mesodermal sources have yet
to be defined.
Mouse genetic studies have shown that ventral and dorsal
pancreatic patterning also requires a different set of transcription
factors. The transcription factor Ptf1a is necessary for the
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(Kawaguchi et al., 2002); the homebox genes Isl1 andHlxb9 are
necessary for the specification of dorsal but not ventral
pancreatic cells (Ahlgren et al., 1997; Harrison et al., 1999; Li
et al., 1999). Furthermore, in Xenopus and zebrafish embryos,
the dorsal and ventral pancreatic anlages undergo distinct
differentiation programs, giving rise to spatially segregated
endocrine and exocrine precursors (Kelly and Melton, 2000;
Lin et al., 2004). Insulin expression is confined to the dorsal
pancreas, whereas exocrine cells seem to arise from the ventral
pancreas (Kelly and Melton, 2000; Lin et al., 2004).
Despite intense scrutiny surrounding β-cell differentiation in
vitro and genetic dissection of specific pancreatic transcription
factors, early specification of the endoderm toward a pancreatic
fate is still poorly understood (Edlund, 2002; Grapin-Botton and
Melton, 2000). Instructive signals able to establish a pancreatic
domain within the endoderm are still to be identified. To address
these issues, we carried out a large-scale screen to identify
molecular players involved in pancreatic induction in Xenopus
embryos. We focused on the dorsal pancreatic rudiment, where
insulin-producing cells are specified in Xenopus. Our gain-of-
function expression cloning screen led to the identification of
Shirin, a previously uncharacterized gene that marks the
endodermal territory fated to become pancreas during develop-
ment. Interestingly, overexpression of the non-coding sequence
of this novel gene [3′UnTranslated Region (UTR)] is sufficient
to induce ectopic insulin expression in the embryo. Biochemical
dissection of the Shirin 3′UTR insulin-inducing activity
indicates that this RNA sequence is the target of the RNA-
binding protein, Vg1RBP (also known as Vera in Xenopus),
previously shown to be involved in the localization of RNAs
encoding endodermal determinant factors (Deshler et al., 1998;
Havin et al., 1998). Finally, we show that Vg1RBP is necessary
for pancreatic induction by demonstrating that depletion of
Vg1RBP activity in the embryo severely and specifically
impairs pancreatic formation.
Results
Expression cloning screen to characterize factors involved in
early pancreatic development
In an effort to identify factors implicated in early pancreatic
development, we carried out an expression cloning screen in
Xenopus laevis embryos (Grammer et al., 2000; Weinstein et al.,
1998). Pools containing 100 transcribed cDNAs from a gastrula
stage expression library were injected into vegetal blastomeres
of eight-cell stage embryos. We targeted the vegetal pole
because this is the region of the embryo fated to give rise to all
the endodermal derivatives (Dale and Slack, 1987). Injected
embryos were allowed to develop to tadpole stage and analyzed
for changes in pancreas organogenesis, by examining the
expression of the pancreatic cell specific marker, insulin, by
whole-mount in situ hybridization (Fig. 1A). Insulinwas chosen
as a marker of pancreatic differentiation in our screen for its
relatively early and specific expression in the dorsal pancreatic
rudiment of Xenopus embryos (Kelly and Melton, 2000).We identified one positive pool (pool 904) that induced
robust ectopic expression of insulin along the gut in addition to
its endogenous expression (Fig. 1A). By sib-selection, we
isolated one individual clone that possessed this insulin-
inducing activity, referred to as 904-4 D7. Sectioning of the
embryos after whole-mount in situ hybridization confirmed
induction of insulin expression following the injection of the
single clone 904-4 D7 RNA (Fig. 1A).
To examine if this clone had general endodermal induction
ability, we tested its activity in the context of the ectoderm. 904-
4 D7 RNA was injected into the animal pole of two-cell stage
embryos. Unlike the vegetal pole, the animal pole is fated to
give rise solely to ectodermal derivatives and does not
contribute to the endoderm (Dale and Slack, 1987). Fig. 1B
shows that the endoderm-specific factor Mixer (Henry and
Melton, 1998), whose expression is normally confined to the
vegetal pole of the embryo, is strongly and ectopically induced
in the injected cells of the animal pole when these embryos are
examined at gastrulation. This demonstrates that 904-4 D7 can
act as an inducer of endoderm in vivo.
For a more precise characterization of endoderm induced by
this clone, ectodermal explants were derived from injected
embryos at blastula stage, cultured until gastrula (stage 11) and
late tailbud stage (stage 32) and examined by RT-PCR for the
expression of endodermal specific markers (animal cap assay)
(Fig. 1C and Supplemental Fig. S1). Fig. 1C shows that 904-4
D7 induced the pan-endodermal marker endodermin (Sasai et
al., 1996) and insulin in ectodermal explants. Interestingly, the
expression of Pdx-1 (aka Xlhbox8 in Xenopus), a marker of
endodermal cells fated to develop into pancreas/duodenum, was
not detected (Fig. 1C; see discussion) (Ahlgren et al., 1998;
Gamer and Wright, 1995; Henry et al., 1996). In addition, we
did not observe induction of other endodermal derivatives, as
judged by the absence of the expression of the hepatic marker,
Hex (Bort et al., 2004), and of mesodermal cells (Fig. 1C and
Supplemental Fig. S1). Finally, the neural specific marker,
NCAM, was not induced in these explants, indicating that these
insulin-expressing cells are not of neuronal origin (Weinstein et
al., 1998).
These results suggest that 904-4 D7 converts embryonic cells
first into an endodermal fate and then specifically into insulin-
producing cells. Because of its embryological activity, we have
named the clone 904-4 D7 Shirin after the Persian word
meaning sweet.
Shirin cDNA contains only non-coding sequence (3′UTR) of a
novel Xenopus gene
Sequence analysis revealed that the active Shirin clone
contains a non-coding sequence, corresponding to the last 400
nucleotides of the 3′UTR of a previously uncharacterized
Xenopus gene. The fact that a 3′UTR could have this inducing
ability was surprising and prompted us to isolate the full-length
gene. The full-length Shirin (GenBank accession number
AY634313) contains a 3.5-kb open reading frame (ORF)
encoding a putative 1001-amino acid protein with two con-
served domains: one Rho GTPase-activating protein (GAP)
Fig. 1. Expression cloning of novel inducers of pancreatic fate. (A) Pools of 100 RNAs from a gastrula-stage cDNA library were injected into vegetal blastomeres of
eight-cell stage Xenopus embryos. Tadpole stage embryos were hybridized to an antisense insulin probe. Whole-mount in situ hybridization using antisense insulin
probe, top to bottom: uninjected embryo; embryo injected with 1 ng of 904 pool RNA; vibratome section of embryo injected with the single clone 904-4 D7 RNA.
Arrowheads indicate endogenous insulin staining; brackets indicate ectopic insulin expression. An indicates animal pole; Veg indicates vegetal pole. (B) Gastrula stage
embryo injected animally with 904-4 D7 and hybridized to an antisense mixer probe. Arrowheads indicate endogenous mixer staining; bracket indicates ectopic mixer
expression in the ectoderm. An indicates animal pole; Veg indicates vegetal pole. (C) RT-PCR analysis of animal caps injected with 1 ng 904-4 D7 RNA and cultured
until stage 32 (tailbud). Muscle Actin (MA) was used as marker of mesodermal cells at tailbud stage. ODC was used as a loading control for RT-PCR.
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(Fig. 2A) (Peck et al., 2002; Soccio and Breslow, 2003). This
sequence shows high similarity to the humanDLC2 (forDeleted
in Liver Cancer 2) gene (Ching et al., 2003). DLC2 encodes a
novel RhoGAP protein and, together with the closely related
DLC1 protein, forms a distinct and evolutionary conserved
group of GAP proteins underexpressed in human hepatocellular
carcinoma tissues as well as other tumors and are considered
candidate tumor suppressor genes (Ching et al., 2003; Nagaraja
and Kandpal, 2004; Peck et al., 2002; Yuan et al., 1998).
Besides the observations that the RhoGAP domain of hDLC2 is
responsible for suppressing Ras signaling and counteracts Ras-
mediated cellular transformation in mammalian cell culture,
very little is known about the biological function of this protein,
and in particular, no embryological function has been assigned
to it (Ching et al., 2003).
To determine whether the full-length gene also possesses an
insulin-inducing activity or this activity is confined to the 3′
UTR, we tested the full-length Shirin RNA and a 3′UTR
truncated Shirin (Shirin-MUT) in an animal cap assay.
Interestingly, RT-PCR analysis revealed an induction of insulin
expression only in the presence of the 3′UTR (Fig. 2A). Thisresult indicates that the Shirin ORF is not responsible for the
cell fate change and demonstrates that the 3′UTR is sufficient
for inducing insulin expression in the embryo.
To investigate whether Shirin is expressed at the appropriate
time and location to influence in vivo endodermal/pancreatic
fate decision, we analyzed its profile of expression during early
and late embryogenesis. At early gastrula stage, when the
dorsal lip is formed, Shirin is strongly expressed in the dorsal
endoderm just below the organizer (Fig. 2B), precisely where
the pancreatic rudiment is specified (Henry et al., 1996; Kelly
and Melton, 2000). At neurula stage, Shirin is expressed in the
dorsal middle portion of the archenteron roof, which
contributes to the dorsal pancreatic bud (Chalmers and Slack,
2000). In addition, its expression is detected in the dorsal
mesoderm, involuting mesoderm and the sensorial layer of the
ectoderm (Fig. 2C). Starting at late tailbud-early tadpole stage
(stages 30–35), Shirin is detected in endodermal cells within
the dorsal pancreatic rudiment and in the surrounding
mesenchymal layer (Fig. 2D). Staining for Shirin RNA
expression is also detected in the notochord and neural tube,
suggesting additional functions for this gene in different
contexts (Fig. 2D). Finally, at late tadpole stage (stage 43),
Fig. 2. Shirin insulin-inducing activity is mapped to its 3′UTR sequence. (A) On
the left, schematic representation of Shirin full-length, showing the RhoGAP
(light blue) and START (dark blue) domains. The last 400 nucleotides (nt)
corresponding to the clone 904-4 D7 (referred to as Shirin 3′UTR) are in green.
On the right, animal caps injected with 60 pg of Shirin RNA and Shirin-MUT
RNA, which lacks the 3′UTR, at the two-cell stage and analyzed for the
expression of insulin by RT-PCR at stage 32 (tailbud). (B–E) Shirin mRNA
distribution during embryogenesis. (B) At gastrula stage, Shirin is detected at
high level in dorsal vegetal cells by whole-mount in situ hybridization.
Arrowheads indicate the dorsal lip. (C) Vibratome section of whole-mount in
situ hybridization of embryo at neurula stage. Arrowhead indicates the
expression of Shirin in the middle dorsal portion of the archenteron roof. (D)
Shirin expression in a transverse section of a stage 33 tadpole. Arrow marks
expression in dorsal mesodermal layer. Expression within endodermal cells is
shown by a arrowhead. (E) At late tadpole stage, the expression of Shirin is
confined to the pancreatic–duodenal region of Xenopus gut. Abbreviations: dp,
dorsal pancreatic rudiment; nc, notochord; nt, neural tube; pa, pancreas.
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region of the gut, as observed by in situ hybridization on
dissected whole gut (Fig. 2E). This highly specific domain of
expression of Shirin, first in the dorsal endoderm and then in
the pancreas, suggests a potential role in vivo in early
specification of the pre-pancreatic domain.
Biochemical mechanism of the Shirin 3′UTR activity
In general, non-coding RNA, and UTRs in particular, have
been previously shown to control cell fate determination during
embryogenesis in a variety of organisms (Ambros, 2004; Bartel,
2004; Kuersten and Goodwin, 2003). For 3′UTRs both cis-acting mechanisms, in which the UTR influences the expression
of its own ORF, as well as trans-acting mechanisms, in which
the UTR controls the expression of ORFs other than its own,
have been reported (Kuersten and Goodwin, 2003; Rastinejad
and Blau, 1993). For instance, a regulatory function in trans for
UTRs in control of differentiation and growth of myogenic cell
lines has been suggested (Rastinejad and Blau, 1993). Also, a
trans-dominant RNA mechanism has been described as the
mechanism of pathogenesis of the myotonic dystrophy (DM)
syndrome: recruitment of different RNA-binding proteins by a
CGT expansion located in the 3′UTR of the DMPK (for
Dystrophia Myotonica-Protein Kinase) gene is the cause of the
disease, rather than the protein coding portion of the gene itself
(Ranum and Day, 2004). While Shirin 3′UTR might function
either in cis, trans, or both, the fact that its ORF is not required
for induction of insulin strongly points to a trans-acting
mechanism (Fig. 2A).
To investigate this mechanism, we started by addressing
whether this UTR sequence contains any structural signatures.
We hypothesized that its activity may be mediated either
directly by the RNA itself (e.g., secondary structure, micro-
RNAs, antisense), or by an RNA–protein interaction, which can
result in sequestration of an inhibitor or recruitment of an
activator. A detailed analysis of the Shirin 3′UTR RNA
sequence highlighted several significant RNA motifs (Fig.
3A). Some of these elements are determinants of RNA
instability in vertebrates, such as the AU-Rich Element
(ARE), the Embryo Deadenylation Element (EDEN), and the
K-box sequence motifs (Fig. 3A) (Chen and Shyu, 1995; Lai et
al., 1998). While the destabilizing function of these motifs has
been shown to be regulated by proteins that bind them, recent
evidence demonstrates that both the ARE and K-box sequence
motifs are also targets of microRNAs, suggesting a cooperation
between microRNAs and binding proteins (Jing et al., 2005; Lai
et al., 2005). Intriguingly, we also found motifs known to be
crucial for proper localization of determinant RNAs, such as
Vg1 (Weeks and Melton, 1987), within the future endodermal
territory of the early Xenopus embryo, referred as Vg1 Motif
(VM) 1 and E2 motif (Fig. 3A) (Cote et al., 1999; Deshler et al.,
1998; Havin et al., 1998).
Other than the described motifs, in our extensive search
(see Experimental procedures), we did not detect any
significant structural motif or hairpin structure, potential
precursor of microRNAs, in Shirin 3′UTR RNA, indicating
the RNA–protein interaction as the more likely mechanism of
action.
To test whether the Shirin 3′UTR sequence is able to bind
one or more proteins, we carried out a UV cross-linking assay
using 32P-labeled Shirin 3′UTR as probe and protein extracts
from Xenopus embryos. As shown in Fig. 3B, we identified at
least three prominent polypeptides bound and cross-linked to
the RNA sequence: one strong protein doublet with an apparent
molecular mass of above 66 kDa, one complex between 46 and
66 kDa and a weaker band between 97 and 200 kDa. All three
protein interactions were shown to be specific, as they were
competed by the presence of specific cold competitor, but not
by the non-specific transcript encoding the polylinker of the
Fig. 3. Analysis of the Shirin 3′UTR sequence. (A) Nucleotide sequence of the entire 3′UTR of Shirin. The last 400 nt corresponding to the clone 904-4 D7 (referred to
as Shirin 3′UTR) are in green in the figure. Predicted sequence features present in Shirin 3′UTR: two potential ARE motifs (red in the figure); two EDENmotifs (blue
in the figure); two K-box sequence motifs (black in the figure); two Vg1 motif 1 (VM1; orange in the figure); and two E2 motifs (purple in the figure). Underlined
sequence indicates the polyA signal. (B) UV cross-linking assay using 32P-Shirin 3′UTR RNA as probe and Xenopus embryo extracts at tadpole stage. In the absence
of competitor RNA (lane 1). Competitions were carried out with 100-fold excess of either specific competitor (sp, unlabeled Shirin 3′UTR; lane 2) or non-specific
competitor (nsp, polylinker of MT-pCS2+; lane 3). As control, the reaction was performed in the absence of probe (lane 4). Proteinase K digestion of the complexes
indicated that the binding factors were proteins (lane 5). Colored arrowheads indicate three major cross-linked proteic complexes. (C) UV cross-linking and
immunoprecipitation assay. As positive control, 32P-VLE (for Vg1 Localization Element) was used as probe (lanes 1–5), and for the immunoprecipitation assay, the
anti-Vg1RBP antibody and rabbit pre-immune serum, as negative control; 32P-Shirin 3′UTR RNA as probe (lanes 6–7), and for the immunoprecipitation assay, the
anti-Vg1RBP antibody and rabbit pre-immune serum, as negative control. Competitions were carried out with 100-fold excess of either non-specific competitor (nsp,
polylinker of MT-pCS2+) or specific competitor (sp, unlabeled specific RNA probes). Vg1RBP is indicated by the blue arrowhead.
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revealed that the region recognized by these three polypeptides
resides within a 200-nt fragment (from nt 202 to 392) (data not
shown). These polypeptides are therefore possible candidates
for mediating the trans activity of Shirin 3′UTR. We pursued
the characterization of these three polypeptides.
The size of the protein doublet (above 66 kDa; indicated
by the blue arrowhead in Fig. 3B) was intriguing in its
similarity to the size of the RNA-binding protein Vg1RBP
(also known as Vera in Xenopus) (Deshler et al., 1998; Havin
et al., 1998). Accordingly, in the Shirin 3′UTR sequence, two
VM1 motifs (one canonical UUUCUA and one possible
UUUCU) and two E2 motifs [(A/U) (C/U) CAC] were
present, and these motifs are known to be critical for Vg1
mRNA localization and for the binding of several trans-actingRNA-binding proteins, including VgRBP60 and Vg1RBP
(Fig. 3A) (Cote et al., 1999; Deshler et al., 1998; Havin et al.,
1998). The VM1 canonical motif and one E2 motif are
localized in the same 200-nt fragment (from nt 202 to 392)
described above. Therefore, we used antisera directed against
VgRBP60 and Vg1RBP to test whether Shirin 3′UTR could
bind to these RNA-binding proteins. Specifically, only the
antibody directed against Vg1RBP immunoprecipitated the
Shirin 3′UTR/protein complex following UV cross-linking
experiment (Fig. 3C and data not shown). We have therefore
characterized one of the three proteins binding Shirin 3′UTR
as Vg1RBP.
To characterize the other potential trans-acting factors
binding the Shirin 3′UTR, we used an RNA affinity
chromatography approach. The 200-nt fragment (from nt 202
447F.M. Spagnoli, A.H. Brivanlou / Developmental Biology 292 (2006) 442–456to 392) of Shirin 3′UTR was coupled to agarose beads and used
to affinity purify factors from Xenopus embryo extracts.
Proteins bound to the immobilized RNA were analyzed by
SDS-PAGE. Two polypeptides with apparent molecular weights
between 40 and 50 kDa were found that bind specifically to the
Shirin 3′UTR, similar to the p46–50 binding activity detected in
the UV cross-linking assay (indicated by the green arrowhead in
Fig. 3B). The identities of these proteins were determined by
MS/MS electrospray mass spectrometry (Supplemental Figs.
S2A-C). One polypeptide corresponds to the heterogeneous
nuclear ribonucleoprotein (hnRNP) A/B, a well-known RNA-
binding protein involved in pre-mRNA processing as well as
transport, localization, translation, and stability of mRNAs
(Supplemental Figs. S2A and B) (Caputi et al., 1999; Dreyfuss
et al., 2002; St Johnston, 2005). The second one is the Xenopus
homolog of the human Interleukin enhancer binding factor 2
(Ilf2) (Supplemental Fig. S2C). This protein, originally
characterized as the transcription factor Nuclear Factor of
Activated T Cells (NFAT), is also an RNA-binding protein
(Shin et al., 2002).
By a broad biochemical approach, we identified three
different RNA-binding proteins able to interact with the Shirin
3′UTR. Next, we asked functionally whether any of these trans-
acting factors can induce or inhibit insulin expression and,
thereby, mediate Shirin 3′UTR activity.
Characterization of the interaction between Shirin 3′UTR and
Vg1RBP
The pattern of expression of Vg1RBP and preliminary
functional analysis of its mammalian homologs pointed to
Vg1RBP as the most promising candidate in mediating Shirin 3′
UTR activity (Hansen et al., 2004; Wagner et al., 2003; Yaniv
and Yisraeli, 2002). In contrast, no observations suggesting an
involvement of either hnRNPA/B or Ilf2 in endodermal tissue
formation have been described so far (Dreyfuss et al., 2002;
Shin et al., 2002).
Vg1RBP and its homologs in zebrafish, mouse, and human
(known as KOC for KH domain containing protein over-
expressed in cancer or IMPs for IGFII mRNA-binding
proteins) show a biphasic expression with an initial maternal
component and later zygotic transcription (Yaniv and Yisraeli,
2002). Maternal Vg1RBP specifically accumulates in the
vegetal pole, which fate maps to endoderm, and plays a role
in the specification of this germ layer through the localization
of the Vg1 RNA (Havin et al., 1998; Zhang et al., 1999). After
gastrulation, in vertebrates Vg1RBP is expressed in a variety of
tissues, including endodermal derivatives, such as liver
diverticulum, pancreas and hindgut (Supplemental Fig. S3C)
as well as in the dorsolateral plate mesoderm surrounding the
pre-pancreatic endoderm (Supplemental Figs. S3A-B′) (Yaniv
and Yisraeli, 2002). The partial colocalization of Vg1RBP and
Shirin, mainly where the dorsal pancreatic rudiment is
specified either at very early or late stages of embryonic
development, is suggestive of an interaction between the two
molecules (Fig. 2 and Supplemental Figs. S3A–C) (Yaniv and
Yisraeli, 2002).In order to assess the significance of Vg1RBP interaction
with Shirin 3′UTR in the context of pancreatic induction, we
performed two sets of experiments designed to test the necessity
of this interaction for insulin induction. Both experiments
interfere with the ability of Vg1RBP to interact with Shirin 3′
UTR. In the first experiment, we performed site-directed
mutagenesis of all four Vg1RBP-binding motifs (Fig. 4A)
and assayed these mutations for their ability to induce insulin
in animal cap explants. Mutation of the four binding sites led
to the elimination of the Shirin 3′UTR insulin-inducing
ability. Fig. 4B shows the result of one such experiment. This
result indicates that the VM1 and E2 binding sites are
necessary for functional interaction between Shirin 3′UTR
and Vg1RBP.
In our second approach, we prevented the in vivo interaction
between Shirin 3′UTR and Vg1RBP, by using an antisense-
based strategy. 2′-O-methyl RNA oligoribonucleotides
designed against two different regions of the Shirin 3′UTR
sequence that contain Vg1RBP-binding motifs were injected
into the embryos (Fig. 4A). The 2′-O-methyl modification
protects the oligoribonucleotides from nuclease degradation and
allows a very stable hybridization to single-stranded RNA in a
sequence-specific fashion (Grunweller et al., 2003). For these
reasons, they are considered to act through a steric blocking
mechanism rather than RNAse H-cleavage (Chiang et al., 1991;
Grunweller et al., 2003). The ability of these antisense
oligoribonucleotides (AS) to interfere with the binding of the
protein Vg1RBP to Shirin 3′UTR was tested by UV cross-
linking assay, using 32P-labeled Shirin 3′UTR as probe and
protein extracts from Xenopus embryos (Figs. 4A and C). Both
AS1 (Fig. 4C) and AS2 (data not shown) block the ability of
Shirin 3′UTR to interact with the Vg1RBP protein. The
antisense-binding activity is sequence-specific, as they do not
affect the interaction of Vg1RBP with the same E2/VM1 motifs
in the context of different 3′UTR sequences (Supplemental Fig.
S3D). Subsequently, we investigated the consequence of this
loss-of-binding directly in the embryos by analyzing the level of
expression of specific pancreatic markers at the earliest time of
their induction in Xenopus embryos. Importantly, injection of
AS1 and AS2 oligoribonucleotides into the vegetal pole of the
embryo induced a decrease of the expression level of insulin, as
assessed by quantitative real-time RT-PCR (Fig. 4D and data not
shown). Similar effect was observed on the expression of Pdx1,
while the level of the intermediate-posterior gut marker,
intestinal fatty acid binding protein (IFABP) remains unchanged
(Fig. 4D) (Henry et al., 1996). At earlier developmental stage
(gastrula), perturbation of endodermal specification was also
observed in AS1-injected embryos, as judged by the down-
regulation of the mesendodermal marker, mix.1, and unchanged
level of the pan-mesodermal marker, BU (Fig. 4E). The effects
observed at gastrula stage appear to be milder when compared to
the insulin expression effect, suggesting a role for the Vg1RBP-
Shirin 3′UTR interaction at later developmental stages.
Taken together, the evidences presented above demonstrate
that the Vg1RBP-binding sites within Shirin 3′UTR sequence
are necessary for its insulin-inducing ability, not only in
overexpression study, but also in vivo.
Fig. 4. Disruption of the Shirin 3′UTR and Vg1RBP RNA–protein interaction results in loss of Shirin insulin-inducing activity. (A) Nucleotide sequence of Shirin 3′
UTR from nt 241 to nt 606, showing two VM1 (orange in the figure) and two E2 motifs (purple in the figure). Underlined sequences indicate single nucleotide
substitutions within the VM1 (U→G) and E2 (C→G) motifs. Sequences highlighted in yellow correspond to the sequences targeted by the 2′-O-Me antisense
oligoribonucleotides (AS1 and AS2). Sense oligoribonucleotides were used as control. (B) Mutational analysis of Vg1RBP-binding motifs in the Shirin 3′UTR
sequence. Animal caps injected with 1 ng of wild-type Shirin 3′UTR and mutated Shirin 3′UTR, bearing point mutations in all the four Vg1RBP-binding sites
(indicated as MUT. 4), at the two-cell stage and analyzed for the expression of insulin by RT-PCR at stage 32 (tailbud). (C) UV cross-linking assay using 32P-Shirin 3′
UTR RNA as probe and Xenopus embryo extracts at tadpole stage. In the absence of competitor RNA (lane 1). Competitions were carried out with 100-fold excess of
specific competitor (sp, unlabeled Shirin 3′UTR; lane 2), non-specific competitor (nsp, polylinker of MT-pCS2+; lane 3), 10 μM AS1 (lane 4). Colored arrowheads
indicate three major cross-linked proteic complexes. (D) Real-time RT-PCR analysis of Xenopus embryos injected with 2′-O-Me antisense oligoribonucleotides. Two-
cell stage embryos injected with 10 μM oligoribonucleotides (AS1 and S1) into the vegetal pole were analyzed for the expression of insulin, Pdx1, and IFABP by
quantitative real-time RT-PCR at stage 32 (tailbud). The plot shows the regulation (expression ratio) of the target genes in injected embryos versus uninjected embryos
(the control group). All the values were normalized to the reference gene, ODC, and calculated using the software REST© (Relative Expression Software Tool) (Pfaffl
et al., 2002). In embryos injected with sense oligoribonucleotide sequence (S1), the expression of insulin and Pdx1 was unaffected. The experiment was repeated three
times, and each time, two embryos for each condition (AS1-injected, S1-injected, uninjected) were examined. Data were determined in triplets. Similar observations
were made also with the oligoribonucleotides AS2 and S2 (data not shown). (E) Real-time RT-PCR analysis of Xenopus embryos injected with 2′-O-Me antisense
oligoribonucleotides. Two-cell stage embryos injected with 10 μM oligoribonucleotides (AS1 and S1) into the vegetal pole were analyzed for the expression of mix.1
and BU by quantitative real-time RT-PCR at gastrula stage.
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rudiment
To investigate the biological role in vivo of Vg1RBP during
the formation of endodermal derivatives and, specifically, of the
pancreatic rudiment, we performed both gain- and loss-of-
function of Vg1RBP experiments. We knocked down the level
of expression of the protein using antisense morpholino
oligonucleotides (Vg1RBPMo) (Supplemental Fig. S4) (YanivFig. 5. Vg1RBP is required for pancreas formation. (A)Whole-mount in situ hybridiza
left to right: uninjected embryo, arrow indicates insulin expression in the pancreas; tw
coiling and looping on the right side of the gut; dorsal view of an embryo injected wi
effects of Vg1RBPMo are specific to the developing gut. Bottom panel, left to right:
first loop of the small intestine posterior to the stomach; embryos injected with 10 ng
0.5 ng Vg1RBP RNA rescues coiling of the anterior portion of the gut and expression
embryos, stage 33. Top, left to right: uninjected embryos, arrowhead indicates insulin
of Vg1RBPMo, as indicated. Bottom, left to right: embryos injected with 10 ng C
expression of insulin in the dorsal pancreatic rudiment. (C, C′) Higher magnificatio
benzoate/Benzyl alcohol (C′) confirmed the absence of insulin-staining cells.et al., 2003). To inhibit the translation of Vg1RBP mRNA
specifically within the territory where pancreas is formed, we
injected the Vg1RBPMo into the dorsal vegetal blastomeres of
eight-cell stage embryos. Inhibition of Vg1RBP function in the
dorsal vegetal half of the embryo resulted in a specific gut
phenotype, morphologically visible at late tadpole stage (Fig.
5A). Vg1RBPMo impaired anterior gut morphogenesis, includ-
ing incomplete coiling of the gut and apparent loss of pancreatic
tissue on the right side of the gut (Fig. 5A). The effect ontion using antisense insulin probe in embryos, stage 43. Ventral views. Top panel,
o embryos injected with 10 ng of Vg1RBPMo, arrowheads indicate defects in gut
th 10 ng of Vg1RBPMo shows no phenotypic abnormalities, suggesting that the
schematic representation of the gut of stage 43 embryo, arrowheads indicate the
Control Morpholino oligonucleotide (CoMo) ; coinjection of Vg1RBPMo with
of insulin in the pancreas. (B) Whole-mount in situ hybridization for insulin in
expression in the dorsal pancreatic bud; embryos injected with either 5 or 10 ng
oMo; coinjection of Vg1RBPMo with 0.5 ng Vg1RBP RNA rescues normal
n of one of the 10 ng Vg1RBPMo-injected embryos in (B). Clearing in Benzyl
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analysis using an insulin probe in antisense-injected embryos
cultured to stage 43–44 (Fig. 5A). These effects were dose-
dependent, highly penetrant and specific to the action of
Vg1RBPMo (Fig. 5; Supplemental Fig. S4) (Yaniv et al., 2003).
Notably, as the most stringent test of specificity, we were able
to rescue the mutant phenotype with Vg1RBP encoding
RNA. When Vg1RBP RNA lacking the 5′UTR sequence,
targeted by the Vg1RBPMo, was injected simultaneously into
the embryos along with the antisense morpholino, the expres-
sion of insulin was effectively rescued in a large proportion of
these embryos (more than 70%), indicating that the effect of
Vg1RBPMo is specific (Fig. 5; Supplemental Fig. S4).
To determine whether the depletion of Vg1RBP activity
affects the specification of the pancreatic rudiment, we analyzedFig. 6. Specific effect of Vg1RBP depletion on early pancreatic markers. (A) In situ
injected embryo (injected with 10 ng CoMo) show expression of Pdx1 as a narrow b
injected with 10 ng of Vg1RBPMo. Coinjection of Vg1RBPMo with 0.5 ng Vg1RB
staining in the ventral pancreatic bud. (B) In situ hybridization for Ptf1a in embryos, s
both dorsal (d) and ventral (v) pancreatic buds; embryos injected with 10 ng CoMo. R
Ptf1a staining in the ventral pancreatic bud. (C) In situ hybridization for Hex in emb
endoderm of the liver diverticulum; embryos injected with 10 ng CoMo. Right pane
injected with 10 ng CoMo, 10 ng Vg1RBPMo, and 10 ng Vg1RBPMo + 0.5 ng Vg
Uninjected dorsal vegetal (VD) and ventral vegetal (VV) pole halves were used as
(expression of Pdx1 and insulin is confined to VD; IFABP is expressed in both VVan
assayed by RT-PCR analysis for markers of pancreatic specification (Pdx1 and insuli
60 pg VegT RNA and/or 0.5 ng Vg1RBP RNA, as indicated. Coinjection of VegT + V
and analyzed for expression of late endodermal markers by RT-PCR.the expression of insulin at an earlier embryonic stage. We
found that injection of Vg1RBPMo clearly reduces the number
of insulin-expressing cells in embryos at early tadpole stage in a
dose-dependent manner (Figs. 5B, C, and C′). Following
injection of 10 ng of Vg1RBPMo into the dorsal vegetal
blastomeres of eight-cell stage embryos, no expression of
insulin was detectable at stage 33 (75% of the embryos; Figs.
5B, C, and C′; Supplemental Fig. S4), and the effect was
specifically rescuable (70% of the embryos; Fig. 5B; Supple-
mental Fig. S4). In control Mo-injected (CoMo) embryos, the
insulin staining was unaffected (Fig. 5B). This result shows that
Vg1RBP is necessary for the onset of insulin expression in the
dorsal pancreatic rudiment.
Interestingly, we observed that Pdx1 expression is also
strongly affected by Vg1RBPMo. Fig. 6A shows loss of Pdx1hybridization for Pdx1 in embryos, stage 33. Left panel: uninjected and CoMo-
and in the pancreatic/duodenum endoderm. Right panel, top to bottom: embryos
P RNA rescues normal expression of Pdx1. Arrowhead indicates residual Pdx1
tage 39/40. Left, top to bottom: uninjected embryo shows expression of Ptf1a in
ight panel: embryos injected with 10 ng of Vg1RBPMo. Arrows indicate residual
ryos, stage 37. Left, top to bottom: uninjected embryo shows expression in the
l: embryos injected with 10 ng of Vg1RBPMo. (D) Dorsal vegetal blastomeres
1RBP RNA (indicated as R. for rescue) were dissected at early gastrula stage.
control, for their regional differences in the expression of endodermal markers
d VD) (Henry et al., 1996). All samples were collected at stage 34 (tadpole) and
n) and intermediate-posterior endoderm (IFABP). (E) Animal caps injected with
g1RBP is indicated as V + V. The explants were cultured until stage 34 (tadpole)
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as in the duodenum portion of the gut in Vg1RBPMo-injected
embryos. In a small number of injected embryos, a less severe
reduction of Pdx1mRNAwas observed in the ventral pancreatic
bud (Fig. 6A). The same was also observed for the transcription
factor Ptf1a, whose expression was reduced in Vg1RBP
knockdown embryos (Fig. 6B), mainly in the dorsal pancreatic
bud. The lack of insulin, Pdx1, and Ptf1a suggests that Vg1RBP
is necessary for the general onset of pancreatic induction in the
embryo.
To determine whether Vg1RBP function was specific to the
pancreas or extended to other anterior endodermal derivatives,
we tested its knockdown effect on the specification of the liver
field. In situ hybridization analysis of Hex, an early marker of
hepatic endoderm (Bort et al., 2004), revealed that in the large
majority of cases, the liver field was unaffected in the
Vg1RBPMo-injected embryos (Fig. 6C), suggesting that the
effects of depletion of Vg1RBP activity remain specific to the
pancreas.
Importantly, the severe effects on pancreatic induction upon
Vg1RBPMo injection were confirmed by a semiquantitative
approach, such as RT-PCR analysis (Fig. 6D). In vegetal
explants injected with 10 ng of Vg1RBPMo, the expression of
Pdx1 and insulin was lost (Fig. 6D). Oppositely, the level of the
intermediate posterior gut marker, IFABP (Henry et al., 1996),
remained unchanged (Fig. 6D). This result suggests that the
reduction of pancreatic markers following Vg1RBP depletion is
very likely the result of the specific loss of pancreatic
precursors.
RNA–protein interaction may result in either activation or
disruption of the function of the bound RNA-binding protein
(Ranum and Day, 2004). Our functional analysis identified the
RNA-binding protein, Vg1RBP, as a determinant pancreatic
factor and, therefore, is suggestive of a positive interaction
between Shirin 3′UTR and Vg1RBP protein. Accordingly,
following coinjection of RNA encoding Vg1RBP and Shirin 3′
UTR RNA into the vegetal blastomeres of eight-cell stage
embryo, we observed (i) a cooperative effect between Shirin
3′UTR and Vg1RBP, as judged by the increase of the
frequency of embryos showing ectopic insulin-expressing
cells along the gut (data not shown), and (ii) elevation of
Vg1RBP protein level, as detected by Western Blot analysis
(Supplemental Fig. S3E).
Vg1RBP synergizes with VegT to induce pancreatic fate
While loss-of-function analysis established that Vg1RBP is
necessary for the formation of pancreatic primordium, we
found, in agreement with previously published studies, that
gain-of-function analysis of this gene by microinjection of its
mRNA has no detectable effect on endoderm formation in
vivo (data not shown) (Yaniv et al., 2003). Vg1RBP expression
in animal cap explants also did not elicit an endodermal fate
(Fig. 6E and data not shown). This evidence suggests that
while Vg1RBP is necessary for pancreatic fate establishment, it
is not sufficient. Interestingly, however, if Vg1RBP is
presented simultaneously with a general endodermal inducer,such as the transcription factor VegT (Xanthos et al., 2001), a
synergism is observed (Fig. 6E). More specifically, pancreatic
markers, such as Pdx1 and Ptf1a, were induced upon
coinjection of VegT and Vg1RBP in ectodermal cells (Fig.
6E). Conversely, the level of expression of the transcription
factor Hex appeared slightly reduced in the presence of both
VegT and Vg1RBP. These data indicate that Vg1RBP behaves
as a modifier within the endoderm, specifically promoting
pancreatic fate.
Taken together, these results indicate that Vg1RBP is
required for the early specification of the pancreatic domain
within the endoderm and its proper organogenesis at later stage.
In addition, these functional data together with our biochemical
analysis are suggestive of potential interaction occurring
between Vg1RBP and Shirin 3′UTR in the establishment of
the pancreatic fate.
Discussion
We have used an expression cloning strategy in Xenopus to
identify Shirin, a novel player in endoderm and pancreas
development. Shirin is abundantly expressed in dorsal vegetal
cells at gastrula stage, precisely where the pancreatic anlagen
fate maps, and at late embryonic stages is restricted to the
pancreatic–duodenal region. Interestingly, Shirin's ability to
induce insulin is mediated through its 3′UTR sequence. In the
past few years, an increasing number of developmental
decisions have been reported to rely on control through 3′
UTR elements, though mainly through cis-acting mechanisms
(Gunkel et al., 1998; Kuersten and Goodwin, 2003; St
Johnston, 2005). Here, we propose that Shirin 3′UTR acts in
trans as the protein coding sequence is not required for the
insulin-inducing activity. Our data suggest that the ectopic
expression of insulin induced by Shirin 3′UTR is mediated in
trans through the RNA-binding protein Vg1RBP. In line with
this, we found that Vg1RBP binds to Shirin 3′UTR, can
cooperate with other factors to promote endodermal and
pancreatic cell fate, and is required for the specification of the
pancreatic endoderm and proper expression of insulin during
development.
The evidence presented here suggests a model in which
cooperative interaction between Shirin 3′UTR and Vg1RBP
results in ectopic expression of the insulin along the gut
(Fig. 7). Actually, we demonstrate that the overexpression of
Shirin 3′UTR increases the level of this RNA-binding protein
in the embryo (Supplemental Fig. S3E). Similar observations
were made in the DM disease where CUG RNA repeats titrate
CUG–RNA-binding protein (CUG-BP) out of the free-pool
and increase protein levels by stabilization of CUG-BP
(Timchenko et al., 2001). These findings together with our
data suggest a novel general mechanism, in which RNA-
binding proteins may be protected from degradation when
associated with their target RNA in a protein:RNA complex.
Accordingly, we propose a model in which the function in
vivo of Shirin 3′UTR, in the context of its full-length, might
be to pattern the pancreatic region by stabilizing Vg1RBP
(Fig. 7).
Fig. 7. Model for the trans-acting mechanism of Shirin 3′UTR. (A) Schematic
diagram of early stage embryo (egg-gastrula stage) showing localization of
Vg1RBP protein at the vegetal pole and Shirin transcript in the dorsal vegetal
emisphere. (B) Schematic diagram of tadpole embryo showing insulin-
producing cells in the dorsal pancreatic rudiment (section C) and in ectopic
patches along the gut (section D). (C) Diagram illustrating a transverse section
through the dorsal pancreatic rudiment showing colocalization of Shirin and
Vg1RBP transcripts in the dorsal mesodermal layer surrounding the pancreatic
endoderm. (D) Diagram illustrating a transverse section of the gut following
overexpression of Shirin 3′UTR. Patches of insulin-expressing cells are induced
ectopically. In the box a schematic representation of the Shirin 3′UTR RNA
sequence as a scaffold for factors possibly mediating insulin expression.
Vg1RBP protein is recruited and stabilized by the RNA sequence. Also shown
are the other trans-acting factors that interact with Shirin 3′UTR, such as
hnRNPA/B and Ilf2. Hypothetical Kbox-miRNA duplex is shown as
additional potential mechanism of action of Shirin 3′UTR.
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is consistent with this model. The fact that Shirin and Vg1RBP
colocalize at different times during embryonic development
leads us to hypothesize a stepwise interaction for pancreatic
specification. First, Shirin 3′UTR and Vg1RBP protein are
expressed in the vegetal pole of the embryo where the first
events of endoderm specification occur (Dale and Slack, 1987;
Havin et al., 1998). Although in late oocytes and eggs Vg1RBP
transcript is present in the animal pole of the embryo, its protein
product is tightly localized at the vegetal pole through an
unknown mechanism (Zhang et al., 1999). According to our
results, Shirin 3′UTR may be responsible for the binding and
stabilization of the maternally derived Vg1RBP protein in the
vegetal hemisphere. Subsequently, at tailbud-early tadpole
stage, the two players are coexpressed again in the dorsal
mesodermal layer surrounding the dorsal pancreatic bud, which
is known to impart regional specification to the pre-pancreaticendoderm (Fig. 7; and see below in the discussion) (Horb and
Slack, 2001).
The fact that Shirin is abundantly expressed in additional
sites during embryonic development evokes additional roles of
this gene, independent of Vg1RBP. In this study, we focus on the
specific activity of the Shirin 3′UTR sequence, however, the
role of the coding portion of the gene has yet to be elucidated.
Indeed, Shirin protein contains two well-conserved domains
(RhoGAP and START domains) with uncharacterized roles
during embryonic development (Peck et al., 2002; Soccio and
Breslow, 2003). Further investigations are in progress in this
direction.
Importantly, our discovery of Shirin led us to unravel an
unknown role for Vg1RBP in the formation of pancreas.
Depletion of Vg1RBP protein, specifically in vegetal blas-
tomeres, leads to a dramatic reduction of the expression of
pancreatic markers, such as Pdx1 and insulin, followed by
impairment of organogenesis. If a role for Vg1RBP in
determining early endodermal fate has already been established,
our study shows that Vg1RBP also participates in the
specification of a subset of dorsal endodermal cells, from
which pancreatic rudiment originates. However, although the
endoderm is broadly regionalized at gastrula stage, its final
differentiation occurs at later stages and is dependent on
inductive interactions with the surrounding mesoderm (Horb
and Slack, 2001; Kumar et al., 2003; Wells and Melton, 2000).
Accordingly, a detailed analysis of the pancreatic phenotype in
Vg1RBPMo-injected vegetal explants showed that the loss of
Pdx1 and insulin expression is paralleled by the loss of specific
dorsolateral and gut mesodermal markers (Spagnoli and
Brivanlou, unpublished results). These observations together
with the profile of expression of Vg1RBP indicate that Vg1RBP,
in addition to its cell-autonomous role at earlier stages, may
confer pancreatic regional identity indirectly by exerting an
influence on the surrounding mesoderm. Finally, these
observations are also consistent with the more detrimental
consequences to the dorsal/endocrine than ventral pancreas
observed in Vg1RBPMo-injected embryos. Ptf1a and Hex,
which, in addition to the hepatic field, is also expressed in
mouse ventral pancreatic progenitors (Bort et al., 2004), are
maintained in the ventral pancreatic rudiment. This emphasizes
again the distinct developmental program of the two pancreatic
buds.
It remains to be determined how Vg1RBP influences
pancreatic fate. It has been shown that Vg1RBP controls RNA
localization and translation regulation in different contexts, such
as the oocyte and migrating neural crest cells (Havin et al.,
1998; Nielsen et al., 1999; Yaniv et al., 2003). Thus, we predict
a role for this RNA-binding protein as a post-transcriptional
modulator of local signals patterning the dorsal endoderm in the
embryo. The molecular identities of these signals influencing
pancreatic development still have to be fully characterized.
Importantly, the well-known target of Vg1RBP, the TGFβ
family member, Vg1, is critical for endoderm formation and has
been shown to induce Pdx1 expression (Henry and Melton,
1998; Henry et al., 1996; Weeks and Melton, 1987). Members
of activin and BMP families also represent good candidates, as
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expressed at tailbud in tissues surrounding the pre-pancreatic
endoderm (Kim and Hebrok, 2001; Kumar et al., 2003). It is
likely that these soluble signals require tight translational
control, as, for example, with the secreted proteins that play a
role in the establishment of embryonic polarity in Xenopus and
Drosophila (Wilhelm et al., 2000), and are possible targets of
Vg1RBP. In addition, Vg1RBP might control the migration of
mesenchymal cells around the dorsal pre-pancreatic endoderm,
as it does for the migration of neural crest cells out of the neural
tube (Yaniv et al., 2003). Actually, dorsal mesenchyme is
recruited in its position from an hitherto unknown mesodermal
population (Edsbagge et al., 2005).
Vg1RBP is only one of the trans-acting factors that bind
to the Shirin 3′UTR RNA sequence, and the functional
characterization of the other RNA-binding proteins is still in
progress. It is very likely that the trans-activity of Shirin 3′
UTR is the result of a synergism among different trans-acting
factors with the RNA sequence behaving as a scaffold (Fig.
7C). This “scaffold model” may account for some of the
differences observed between gain-of-function of Shirin 3′
UTR and loss-of-function of Vg1RBP, such as the effect on
Pdx1 expression. Insulin expression is induced by Shirin 3′
UTR in ectodermal explants without induction of Pdx-1.
However, the impairment of the onset of pancreatic induction
in Vg1RBP-Mo injected embryos also affects Pdx1 expres-
sion. One explanation for this discrepancy might be that the
interaction among different trans-acting factors triggers
insulin expression through alternative mechanisms indepen-
dent of or in parallel to Pdx-1. Actually, some insulin-
expressing cells do differentiate in the absence of Pdx1
(Ahlgren et al., 1998; Kumar et al., 2003).
Another very intriguing possibility is that the Shirin 3′
UTR is a target of microRNAs, influencing gene expression
by titrating out these regulatory molecules. Actually, the
K-box and ARE motifs have been recently recognized as
microRNA targets. Both these motifs are present in the Shirin
3′UTR sequence (Jing et al., 2005; Lai, 2002; Lai et al.,
2005).
The molecular mechanisms underlying pancreatic develop-
ment appear very conserved among vertebrates. For example,
Xenopus and zebrafish orthologs have been cloned for almost
all the pancreatic transcription factors with expression patterns
and, in some case, loss-of-function phenotype replicating those
seen in mammals (Kelly and Melton, 2000; Lin et al., 2004). In
the light of these observations, the results of our unbiased screen
in Xenopus may be conserved, and the two players, Shirin and
Vg1RBP, might fulfil similar functions during mammalian
embryogenesis. In support of this, the mouse ortholog of
Vg1RBP is known to be expressed in the pancreatic rudiments
during embryogenesis (Wagner et al., 2003; Yaniv and Yisraeli,
2002). Also, the human ortholog (KOC) is highly expressed in
pancreatic cancer (Yantiss et al., 2005). In addition to the
conserved expression, preliminary functional studies in mouse
suggest a role for both mouse and human Vg1RBP orthologs in
controlling gene expression within endodermally derived
tissues and, more specifically, in the differentiation ofpancreatic tissue (Hansen et al., 2004; Wagner et al., 2003).
In contrast, the mouse Shirin ortholog is still uncharacterized.
Interestingly, the expression of mouse and human orthologs of
Shirin increases in stem cells upon differentiation (Spagnoli and
Brivanlou, unpublished data), suggesting a potential role during
the differentiative program of these cells. However, it has yet to
be established whether mammalian Shirin specifically partici-
pates in the pancreatic cell fate program. This would represent a
significant advance in the search for factors able to induce
insulin expression in stem cells with important implications in
ES cell-based therapy of diabetes.
Recently, global expression analysis and developmental
screens have implicated several RNA-binding proteins in
endoderm/gut development (Kim et al., 2001; Lepourcelet et
al., 2005; Mayer and Fishman, 2003). The Xenopus homolog
of poly(A)-binding protein shows an expression during
embryogenesis gradually confined to the differentiating gut
endoderm (Kim et al., 2001). A zebrafish mutant deficient in
the RNA-binding protein, nil-per-os, shows an arrest of gut
morphogenesis with lack of liver and pancreas (Mayer and
Fishman, 2003). Mouse IMP1 seems to be required for proper
gut development (Hansen et al., 2004). For the first time, we
describe here the requirement of the RNA-binding protein,
Vg1RBP, in pancreatic development. Hence, organogenesis
may be controlled in part by modulating the activity of
putative target RNAs important for digestive organ develop-
ment and homeostasis. In conclusion, we might need to
reconsider the contribution of post-transcriptional versus
transcriptional mechanisms in developmental decisions such




Microinjections and dissections were performed as described (Brivanlou
and Harland, 1989). Antisense morpholinos oligonucleotide used in this study
was directed against the 5′UTR of the pseudoallele Vg1RBP D in a region that
is not homologous to the pseudoallele Vg1RBP A, and the sequence was
published in (Yaniv et al., 2003). Control morpholino corresponds to
Vg1RBPMo sequence with 5 mispairs distributed along the sequence (5′-
AAACAAGATGAGGCCTAAAAACGCG-3′). The oligonucleotides were
purchased from GeneTools LLC. 2′-O-Me oligoribonucleotides with phos-
phorothioate internucleoside linkages were purchased from IDT. Before the
microinjections, all antisense oligos received HPLC and Na+ salt exchange
purification.
Library screen and plasmid construction
Construction of the Xenopus gastrula stage cDNA library was described
previously (Weinstein et al., 1998). Shirin full-length gene was cloned by
screening of a stage 11 Xenopus embryo ZapII library (Brivanlou Laboratory),
using the Shirin 3′UTR original clone as probe. The full-length was subcloned
by PCR strategy into the NotI and XhoI sites of the pCS2++ vector. The Shirin-
MUT was generated by PCR and ligated into pCS2++. The myc-tagged
Vg1RBP was generated by subcloning Vg1RBP ORF without 5′ and 3′UTR
sequences (kindly provided by Yisraeli) into MT-pCS2+. This construct was
used for the rescue experiments. The HA-tagged Vg1RBP, which contains the 5′
UTR sequence, was generated by PCR and ligated into pCS2++. Site-directed
mutagenesis of Shirin 3′UTR was performed by PCR amplification using Quick
454 F.M. Spagnoli, A.H. Brivanlou / Developmental Biology 292 (2006) 442–456Change® Kit (Stratagene). The RNAs for all these constructs were synthesized
on AscI linearized templates, with SP6 RNA polymerase using the mMessage
mMachine kit (Ambion).
In situ hybridization analysis
Whole-mount in situ hybridizations were performed according to (Harland,
1991). Paraffin embedding of tadpole embryos was done as in Kelly and Melton
(2000). Paraffin sections were subjected to in situ hybridization according to
Neubuser et al. (1995).
RT-PCR analysis
RT-PCR was performed as described (Weinstein et al., 1998). Ornithine
decarboxylase (ODC) was used as loading control. For real-time analysis, RT
reactions were performed using the SuperScript III First-Strand Synthesis
System (Invitrogen) according to instructions. Real-time PCR reactions were
carried out using the SYBR Green Master Mix (Applied Biosystems) on an ABI
Prism 7900HT Sequence Detection System.
UV cross-linking and coimmunoprecipitation assays
RNA–protein-binding assay was performed essentially as described
(Gunkel et al., 1998) but with few modifications to adapt it to Xenopus
embryos. Briefly, 10 μg of protein extract was incubated to 1 × 105 cpm of
32P-labeled RNA probes per reaction. The samples were irradiated using a
Stratalinker at 800 mJ on ice and then digested with 10 μg of RNAse for 20
min at 37°C. For competition, the binding mix was pre-incubated with
unlabeled competitor RNAs (100-fold molar excess) for 10 min before adding
the radioactive probe. The samples were then denatured and resolved by
SDS-PAGE. For immunoprecipitation, 10 UV cross-linking reactions were
pooled and incubated with protein A/G agarose beads that had been
preincubated with the appropriate antibody. After incubating at room
temperature for 1 h, unbound proteins were washed with NET-2 buffer (50
mM Tris–HCl pH7.4, 150 mM NaCl, 0.05% NP-40) supplemented with
protease inhibitors (Otero et al., 2001). Search for sequence features in Shirin
3′UTR was made using the 3′UTR database http://www.bighost.area.ba.cnr.it/
BIG/UTRHome/; http://www.rnabase.org/; and RNA mfold version 3.1.
RNA affinity purification assay
Immobilization of RNA on agarose beads and binding assay was performed
essentially as described (Caputi et al., 1999) but with few modifications to
adapt it to Xenopus embryos. Briefly, substrate RNAs for bead immobilization,
including Shirin 3′UTR 200-nt fragment (from nt 202 to 392) and MT-CS2+
polylinker, as negative control, were prepared using T7-Megashortscript kit
(Ambion). RNA (500 pmol) was oxidized with sodium m-periodate and then
covalently linked to adipic acid dihydrazide agarose beads. Proteic extract from
tadpole stage embryos (8–10 mg) was incubated with the beads containing the
immobilized RNA. After several washes, the proteins bound to the
immobilized RNA were eluted and resolved on SDS-PAGE and visualized
by Colloidal Blue Coomassie. The excised bands were sent for sequence
analysis to the Harvard Microchemistry Laboratory. The analysis was
performed by microcapillary reverse-phase HPLC nano-electrospray tandem
mass spectrometry on a Finnigan LCQ DECA XP Plus quadrupole ion trap
mass spectrometer.
Western blot analysis
Whole embryos were lysed in lysis buffer (50 mM Tris pH7.5, 150 mM
NaCl, 1 mM EDTA, 1% glycerol, 0.5% Triton X-100) in the presence of
mini-complete protease inhibitor cocktail (Pierce). The equivalent of 30 μg of
protein extract per sample was resolved in a 9% SDS-PAGE gel, transferred
to Hybond C membrane and probed with 1:50,000 of a Vg1RBP polyclonal
serum (kind gift of Yisraeli); 1:1000 of a myc polyclonal antibody (RDI);
1:10,000 of a α-tubulin monoclonal antibody (Sigma). Quantification was
performed by densitometry of exposed films using the NIH Image software.Acknowledgments
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